Circulating tumor DNA as a predictive biomarker of response to palbociclib-fulvestrant in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

6322446

Reference Type

Journal Article

Title

Circulating tumor DNA as a predictive biomarker of response to palbociclib-fulvestrant in patients with estrogen receptor-positive, HER2-negative metastatic breast cancer

Author(s)

Darrigues, L; Pierga, JY; Bernard, A; Bieche, I; Silveira, A; Michel, M; Sablin, MP; Cottu, P; Dubot, C; Geiss, R; Ricci, F; Proudhon, C; Bidard, FC

Year

2019

Is Peer Reviewed?

Yes

Journal

Cancer Research
ISSN: 0008-5472
EISSN: 1538-7445

Volume

Issue

Page Numbers

P4-01-20-P4-01-20

DOI

10.1158/1538-7445.SABCS18-P4-01-20

Web of Science Id

WOS:000478677001299

URL

https://aacrjournals.org/cancerres/article/79/4_Supplement/P4-01-20/639488/Abstract-P4-01-20-Circulating-tumor-DNA-as-a
Exit